Monocyte derivatives promote angiogenesis and myocyte survival in a model of myocardial infarction

Cell Transplantation

Volumn 19, Issue 4, 2010, Pages 369-386

  Bouchentouf, M ^a   Paradis, P ^a   Forner, K A ^a   Cuerquis, J ^a   Boivin, M N ^a   Zheng, J ^a   Boulassel, M R ^b   Routy, J P ^b   Schiffrin, E L ^a   Galipeau, J ^a  

^a MCGILL UNIVERSITY   (Canada)

^b ROYAL VICTORIA HOSPITAL   (Canada)

Author keywords

Angiogenesis; Apoptosis; Cardiac remodeling; Growth factors; Monocytes; Myocardial infarction; Transplantation

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR RECEPTOR 1; SCATTER FACTOR; SOMATOMEDIN C; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL SURVIVAL; CELL TRANSPLANTATION; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCYTE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; ANIMAL; APOPTOSIS; C57BL MOUSE; CYTOLOGY; DISEASE MODEL; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HEART VENTRICLE REMODELING; METABOLISM; MUSCLE CELL; MYOCARDIAL INFARCTION; TRANSPLANTATION;

MURINAE;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; HEPATOCYTE GROWTH FACTOR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED C57BL; MONOCYTES; MUSCLE CELLS; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; STAUROSPORINE; TUMOR NECROSIS FACTOR-ALPHA; VENTRICULAR REMODELING;

EID: 77953790899     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368909X484266     Document Type: Article

References (54)

1. Aries, A.; Paradis, P.; Lefebvre, C.; Schwartz, R. J.; Nemer, M. Essential role of GATA-4 in cell survival and drug-induced cardiotoxicity. Proc. Natl. Acad. Sci. USA 101(18):6975-6980; 2004.
2. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; van der Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G.; Isner, J. M. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275(5302):964-967; 1997.
3. Badesch, D. B.; Lee, P. D.; Parks, W. C.; Stenmark, K. R. Insulin-like growth factor I stimulates elastin synthesis by bovine pulmonary arterial smooth muscle cells. Biochem. Biophys. Res. Commun. 160(1):382-387; 1989.
4. Banskota, N. K.; Taub, R.; Zellner, K.; Olsen, P.; King, G. L. Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes 38(1):123-129; 1989.
5. Bar, R. S.; Dake, B. L.; Stueck, S. Stimulation of proteoglycans by IGF I and II in microvessel and large vessel endothelial cells. Am. J. Physiol. 253(1 Pt. 1):E21-27; 1987.
6. Bornfeldt, K. E.; Raines, E. W.; Nakano, T.; Graves, L. M.; Krebs, E. G.; Ross, R. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J. Clin. Invest. 93(3):1266-1274; 1994.
7. Brixius, K.; Funcke, F.; Graf, C.; Bloch, W. Endothelial progenitor cells: A new target for the prevention of cardiovascular diseases. Eur. J. Cardiovasc. Prev. Rehabil. 13(5):705-710; 2006.
8. Carlson, D. L.; Lightfoot, Jr., E.; Bryant, D. D.; Haudek, S. B.; Maass, D.; Horton, J.; Giroir, B. P. Burn plasma mediates cardiac myocyte apoptosis via endotoxin. Am. J. Physiol. Heart Circ. Physiol. 282(5):H1907-1914; 2002.
9. Carmeliet, P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6(4):389-395; 2000.
10. Chen, J.; Somanath, P. R.; Razorenova, O.; Chen, W. S.; Hay, N.; Bornstein, P.; Byzova, T. V. Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo. Nat. Med. 11(11):1188-1196; 2005.
11. Chen, X. H.; Minatoguchi, S.; Kosai, K.; Yuge, K.; Takahashi, T.; Arai, M.; Wang, N.; Misao, Y.; Lu, C.; Onogi, H.; Kobayashi, H.; Yasuda, S.; Ezaki, M.; Ushikoshi, H.; Takemura, G.; Fujiwara, T.; Fujiwara, H. In vivo hepatocyte growth factor gene transfer reduces myocardial ischemia-reperfusion injury through its multiple actions. J. Card. Fail. 13(10):874-883; 2007.
12. Claycomb, W. C.; Lanson, Jr., N. A.; Stallworth, B. S.; Egeland, D. B.; Delcarpio, J. B.; Bahinski, A.; Izzo, Jr., N. J. HL-1 cells: A cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc. Natl. Acad. Sci. USA 95(6):2979-2984; 1998.
13. Comoglio, P. M.; Boccaccio, C. Scatter factors and invasive growth. Semin. Cancer Biol. 11(2):153-165; 2001.
14. Eckle, T.; Grenz, A.; Kohler, D.; Redel, A.; Falk, M.; Rolauffs, B.; Osswald, H.; Kehl, F.; Eltzschig, H. K. Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am. J. Physiol. Heart Circ. Physiol. 291(5):H2533-2540; 2006.
15. Fernandez Pujol, B.; Lucibello, F. C.; Gehling, U. M.; Lindemann, K.; Weidner, N.; Zuzarte, M. L.; Adamkiewicz, J.; Elsasser, H. P.; Muller, R.; Havemann, K. Endothelial-like cells derived from human CD14 positive monocytes. Differentiation 65(5):287-300; 2000. (Pubitemid 30406634)
16. Fietz, T.; Reufi, B.; Mucke, C.; Thiel, E.; Knauf, W. U. Flow cytometric CD34+ determination in stem cell transplantation: Before or after cryopreservation of grafts? J. Hematother. Stem Cell Res. 11(2):429-435; 2002.
17. Grant, M. B.; Wargovich, T. J.; Ellis, E. A.; Caballero, S.; Mansour, M.; Pepine, C. J. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis? Circulation 89(4):1511-1517; 1994.
18. Gulati, R.; Jevremovic, D.; Peterson, T. E.; Chatterjee, S.; Shah, V.; Vile, R. G.; Simari, R. D. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res. 93(11):1023-1025; 2003.
19. Guo, M.; Song, L. P.; Jiang, Y.; Liu, W.; Yu, Y.; Chen, G. Q. Hypoxia-mimetic agents desferrioxamine and cobalt chloride induce leukemic cell apoptosis through different hypoxia-inducible factor-1alpha independent mechanisms. Apoptosis 11(1):67-77; 2006.
20. Higuchi, M.; Honda, T.; Proske, R. J.; Yeh, E. T. Regulation of reactive oxygen species-induced apoptosis and necrosis by caspase 3-like proteases. Oncogene 17(21):2753-2760; 1998.
21. Hossne, Jr., N. A.; Invitti, A. L.; Buffolo, E.; Azevedo, S.; Rodrigues de Oliveira, J. S.; Stolf, N. G.; Cruz, L. E.; Sanberg, P. R. Refractory angina cell therapy (ReACT) involving autologous bone marrow cells in patients without left ventricular dysfunction: A possible role for monocytes. Cell Transplant. 18(12):1299-1310; 2009.
22. Hung, H. S.; Shyu, W. C.; Tsai, C. H.; Hsu, S. H.; Lin, S. Z. Transplantation of endothelial progenitor cells as therapeutics for cardiovascular diseases. Cell Transplant. 18(9):1003-1012; 2009.
23. Hur, J.; Yoon, C. H.; Kim, H. S.; Choi, J. H.; Kang, H. J.; Hwang, K. K.; Oh, B. H.; Lee, M. M.; Park, Y. B. Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 24(2):288-293; 2004.
24. Iglarz, M.; Touyz, R. M.; Viel, E. C.; Paradis, P.; Amiri, F.; Diep, Q. N.; Schiffrin, E. L. Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid- dependent hypertension. Hypertension 42(4):737-743; 2003.
25. Igreja, C.; Courinha, M.; Cachaco, A. S.; Pereira, T.; Cabecadas, J.; da Silva, M. G.; Dias, S. Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients. Haematologica 92(4):469-477; 2007.
26. Jiang, W.; Hiscox, S.; Matsumoto, K.; Nakamura, T. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit. Rev. Oncol. Hematol. 29(3):209-248; 1999.
27. Kalka, C.; Masuda, H.; Takahashi, T.; Kalka-Moll, W. M.; Silver, M.; Kearney, M.; Li, T.; Isner, J. M.; Asahara, T. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl. Acad. Sci. USA 97(7):3422-3427; 2000.
28. Kawamoto, A.; Gwon, H. C.; Iwaguro, H.; Yamaguchi, J. I.; Uchida, S.; Masuda, H.; Silver, M.; Ma, H.; Kearney, M.; Isner, J. M.; Asahara, T. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103(5):634-637; 2001. (Pubitemid 32144189)
29. Ke, L.; Qi, X. Y.; Dijkhuis, A. J.; Chartier, D.; Nattel, S.; Henning, R. H.; Kampinga, H. H.; Brundel, B. J. Calpain mediates cardiac troponin degradation and contractile dysfunction in atrial fibrillation. J. Mol. Cell. Cardiol. 45(5):685-693; 2008.
30. Kitta, K.; Day, R. M.; Ikeda, T.; Suzuki, Y. J. Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis. Free Radic. Biol. Med. 31(7):902-910; 2001.
31. Kotlyar, A. A.; Vered, Z.; Goldberg, I.; Chouraqui, P.; Nas, D.; Fridman, E.; Chen-Levy, Z.; Fytlovich, S.; Sangiorgi, G.; Spagnoli, L. G.; Orlandi, A.; Savion, N.; Eldar, M.; Scheinowitz, M. Insulin-like growth factor I and II preserve myocardial structure in postinfarct swine. Heart 86(6):693-700; 2001. (Pubitemid 33086893)
32. Leverrier, Y.; Thomas, J.; Mathieu, A. L.; Low, W.; Blanquier, B.; Marvel, J. Role of PI3-kinase in Bcl-X induction and apoptosis inhibition mediated by IL-3 or IGF-1 in Baf-3 cells. Cell Death Differ. 6(3):290-296; 1999. (Pubitemid 29145833)
33. Lopez-Holgado, N.; Alberca, M.; Sanchez-Guijo, F.; Villaron, E.; Almeida, J.; Martin, A.; Armellini, A.; Garcia, C.; Blanco, B.; Sanchez-Abarca, I.; Martin, S.; Perez-Simon, J. A.; Garcia-Sanz, R.; San Miguel, J. F.; del Canizo, M. C. Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers. Cytotherapy 9(1):14-22; 2007.
34. Luttun, A.; Carmeliet, P. De novo vasculogenesis in the heart. Cardiovasc. Res. 58(2):378-389; 2003.
35. Mai, X. L.; Ma, Z. L.; Sun, J. H.; Ju, S. H.; Ma, M.; Teng, G. J. Assessments of proliferation capacity and viability of New Zealand rabbit peripheral blood endothelial progenitor cells labeled with superparamagnetic particles. Cell Transplant. 18(2):171-181; 2009.
36. Marin-Garcia, J.; Goldenthal, M. J. Mitochondria play a critical role in cardioprotection. J. Card. Fail. 10(1):55-66; 2004.
37. Massa, M.; Rosti, V.; Ferrario, M.; Campanelli, R.; Ramajoli, I.; Rosso, R.; De Ferrari, G. M.; Ferlini, M.; Goffredo, L.; Bertoletti, A.; Klersy, C.; Pecci, A.; Moratti, R.; Tavazzi, L. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105(1):199-206; 2005. (Pubitemid 40053083)
38. Metzler, B.; Hammerer-Lercher, A.; Jehle, J.; Dietrich, H.; Pachinger, O.; Xu, Q.; Mair, J. Plasma cardiac troponin T closely correlates with infarct size in a mouse model of acute myocardial infarction. Clin. Chim. Acta 325(1-2):87-90; 2002.
39. Pi, Y.; Goldenthal, M. J.; Marin-Garcia, J. Mitochondrial involvement in IGF-1 induced protection of cardiomyocytes against hypoxia/reoxygenation injury. Mol. Cell. Biochem. 301(1-2):181-189; 2007.
40. Purdie, K. J.; Whitley, G. S.; Johnstone, A. P.; Cartwright, J. E. Hepatocyte growth factor-induced endothelial cell motility is mediated by the upregulation of inducible nitric oxide synthase expression. Cardiovasc. Res. 54(3):659-668; 2002.
41. Rechler, M. M.; Nissley, S. P. The nature and regulation of the receptors for insulin-like growth factors. Annu. Rev. Physiol. 47:425-442; 1985.
42. Rehman, J.; Li, J.; Orschell, C. M.; March, K. L. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107(8):1164-1169; 2003.
43. Salnikow, K.; Donald, S. P.; Bruick, R. K.; Zhitkovich, A.; Phang, J. M.; Kasprzak, K. S. Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress. J. Biol. Chem. 279(39):40337-40344; 2004.
44. Sanberg, P. R.; Park, D. H.; Kuzmin-Nichols, N.; Cruz, E.; Hossne, Jr., N. A.; Buffolo, E.; Willing, A. E. Monocyte transplantation for neural and cardiovascular ischemia repair. J. Cell. Mol. Med.; 2009.
45. Sanders, D. B.; Larson, D. F.; Hunter, K.; Gorman, M.; Yang, B. Comparison of tumor necrosis factor-alpha effect on the expression of iNOS in macrophage and cardiac myocytes. Perfusion 16(1):67-74; 2001.
46. Somanath, P. R.; Razorenova, O. V.; Chen, J.; Byzova, T. V. Akt1 in endothelial cell and angiogenesis. Cell Cycle 5(5):512-518; 2006.
47. Stahelin, B. J.; Marti, U.; Solioz, M.; Zimmermann, H.; Reichen, J. False positive staining in the TUNEL assay to detect apoptosis in liver and intestine is caused by endogenous nucleases and inhibited by diethyl pyrocarbonate. Mol. Pathol. 51(4):204-208; 1998.
48. Takahashi, T.; Kalka, C.; Masuda, H.; Chen, D.; Silver, M.; Kearney, M.; Magner, M.; Isner, J. M.; Asahara, T. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat. Med. 5(4):434-438; 1999.
49. Urbich, C.; Aicher, A.; Heeschen, C.; Dernbach, E.; Hofmann, W. K.; Zeiher, A. M.; Dimmeler, S. Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J. Mol. Cell. Cardiol. 39(5):733-742; 2005.
50. Ward, M. R.; Stewart, D. J.; Kutryk, M. J. Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: Current perspectives. Catheter Cardiovasc. Interv. 70(7):983-998; 2007.
51. White, S. M.; Constantin, P. E.; Claycomb, W. C. Cardiac physiology at the cellular level: Use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function. Am. J. Physiol. Heart Circ. Physiol. 286(3):H823-829; 2004.
52. Yan, H.; Peng, Z. G.; Wu, Y. L.; Jiang, Y.; Yu, Y.; Huang, Y.; Zhu, Y. S.; Zhao, Q.; Chen, G. Q. Hypoxiasimulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells. Haematologica 90(12):1607-1616; 2005.
53. Zhang, Y. W.; Su, Y.; Volpert, O. V.; Vande Woude, G. F. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc. Natl. Acad. Sci. USA 100(22):12718-12723; 2003.
54. Ziebart, T.; Yoon, C. H.; Trepels, T.; Wietelmann, A.; Braun, T.; Kiessling, F.; Stein, S.; Grez, M.; Ihling, C.; Muhly-Reinholz, M.; Carmona, G.; Urbich, C.; Zeiher, A. M.; Dimmeler, S. Sustained persistence of transplanted proangiogenic cells contributes to neovascularization and cardiac function after ischemia. Circ. Res. 103(11):1327-1334; 2008.